Since the PI3K/AKT and the RAS/MAPK pathways are the major downstream pathways of EGFR signaling [38], we evaluated whether these pathways regulate the expression of NKG2D ligands in the NSCLC cells. Here, AKT1 is linked to non-small cell lung carcinoma.